GSK plc (GSK, GSK.L) announced the European Medicine Agency's Committee for Medicinal Products for Human Use or CHMP has recommended ...

The new vaccine is a combination of GSK’s already-approved vaccines Bexsero and Menveo and is designed to protect against meningitis and blood poisoning caused by the A, B, C, W, and Y ...

EMA’s human medicines committee recommends approval of GSK’s single-vial, fully liquid presentation of Menveo meningococcal vaccine: London, UK Wednesday, September 25, 2024, ...

Pharmaceutical and biotechnology company GSK said on Tuesday that the European Medicine Agency has recommended meningococcal ...

In February 2010, a quadrivalent conjugate vaccine (Menveo; Novartis Vaccines and Diagnostics) was approved by the US FDA to prevent invasive meningococcal disease caused by Neisseria meningitidis ...

If approved, the fully liquid presentation will offer healthcare providers an option that does not require reconstitution of Menveo (MenACWY vaccine) before use · Marketing authorisation in EU ...

The European stock markets closed higher in Tuesday trading as the Stoxx Europe 600 rose 0.58%, the Swiss Market Index climbed 0.70%, France's CAC increased 1.28%, the FTSE in London gained 0.28%, and ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

Birth in the U.S. before 1980 acceptable only for non-health science students Meningococcal conjugate quadrivalent (A,C,Y,W-135) (Menactra, Menveo or Nimenrix only) 1 dose; 1 dose MenACWY (formerly ...

(Alliance News) - GSK PLC on Tuesday announced a new positive opinion from the EU's European Medicine Agency's Committee for Medicinal Products for Human Use. The London-based pharmaceutical company ...

The London-based pharmaceutical company said the committee recommended its new single-vial, fully liquid presentation of its invasive meningococcal disease vaccine Menveo. The recommendation is ...

GSK PLC on Tuesday announced a new positive opinion from the EU's European Medicine Agency's Committee for Medicinal ... Subscribe now to see this Premium News article from Alliance News ...